How are modified nucleotides described in a patent application?
Modified nucleotides in patent applications are described according to MPEP 2412.05(b) as follows: Represent modified nucleotides as the corresponding unmodified nucleotides (a, c, g, t) when possible Use the symbol “n” for modified nucleotides that cannot be represented by other symbols Further describe modified nucleotides in a feature table using the feature key “modified_base” Use…
Read More